Awais Humayun, MD
Clinical Cardiac Electrophysiology · Davie, FLNPI 1346288768
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (36.8%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Abbott accounts for 69.5% of it on its own, with 27 other manufacturers making up the rest. Reporting peaked in 2024 at $29,730 and has fallen 61.9% since, to $11,323 in 2025.
Across 991 payments — averaging $92.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$64K
- Medtronic$19K
- Biotronik Inc.$3K
- Boston Scientific$2K
- Atricure, Inc.$741
- Impulse Dynamics (USA) Inc.$658
- plus $3K from 22 others
Across 115 payments — averaging $4234.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$451K
- Abbott$33K
- Impulse Dynamics (USA) Inc.$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$100
What the payments were for
- Consulting fees$33,87737%
- Speaking & faculty fees$9,30010%
- Travel & lodging$26,90329%
- Food & beverage$22,01924%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 540 | $64,074 |
| Medtronic(2 entities) | 197 | $18,981 |
| Biotronik Inc. | 25 | $2,641 |
| Boston Scientific | 65 | $1,831 |
| Atricure, Inc. | 6 | $741 |
| Impulse Dynamics (USA) Inc. | 9 | $658 |
| Pfizer | 24 | $637 |
| Johnson & Johnson | 25 | $474 |
| Cardiva Medical, Inc. | 16 | $455 |
| E.r. Squibb & Sons, L.L.C. | 22 | $283 |
| Cvrx, Inc. | 12 | $267 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $227 |
| Baxter Healthcare | 5 | $132 |
| Philips North America LLC | 3 | $126 |
| Microport CRM USA Inc | 1 | $106 |
| Sanofi-aventis U.S. LLC | 5 | $81 |
| Portola Pharmaceuticals, LLC | 3 | $65 |
| Kestra Medical Technology Services, Inc. | 2 | $58 |
| Acutus Medical, Inc. | 7 | $57 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $57 |
| Inari Medical, Inc. | 2 | $40 |
| Bardy Diagnostics, Inc. | 1 | $38 |
| Cordis US CORP. | 1 | $23 |
| Preventice Services, LLC | 1 | $22 |
| Boehringer Ingelheim | 1 | $22 |
| Cardiofocus, Inc. | 1 | $17 |
| Altathera Pharmaceuticals LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$31,045
- Arctic Front$7,853
- Fortify Assura, Ellipse ICD$7,057
- Anthem CRT Pacemaker$5,544
- Assurity Pacemaker$3,696
- Accent Pacemaker$3,534
- AVEIR$3,290
- Allure CRT Pacemaker$1,624
- OPTIMIZER$952
- ALLURE$800
- COBALT DR MRI SURESCAN$670
- PulseSelect$665
- Endurity Pacemaker$616
- WATCHMAN Access System$534
- Cobalt$514
- ACCENT$500
- AFFERA MAPPING SYSTEM$465
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$411
- ATRICLIP LAA EXCLUSION SYSTEM$382
- Micra$319
How this compares
$92,142 in reported general payments places this provider in the 85th percentile of 249 clinical cardiac electrophysiology providers in Florida.
See all clinical cardiac electrophysiology providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 334 | $333,559 |
| XareltoRivaroxaban | 76 | $71,805 |
| EntrestoSacubitril/Valsartan | 16 | $21,226 |
| Amiodarone Hcl | 239 | $8,046 |
| Dofetilide | 21 | $5,239 |
| Metoprolol Succinate | 229 | $2,681 |
| Flecainide Acetate | 63 | $2,118 |
| Mexiletine Hcl | 16 | $1,499 |
| SotalolSotalol Hcl | 70 | $1,422 |
| Midodrine Hcl | 17 | $1,397 |
| Propafenone Hcl | 28 | $1,306 |
| Diltiazem Hcl | 26 | $627 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 11 | $440 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 89 | $401 |
| Metoprolol Tartrate | 70 | $373 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $637 | $333,559334 claims |
| Johnson & JohnsonXarelto | $474 | $71,80576 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 249 clinical cardiac electrophysiology providers in Florida.
Other clinical cardiac electrophysiology in Davie
- Usman SiddiquiWinter Park$1.2M
- Jose Osorio FilhoMiami$1.2M
- David KenigsbergFort Lauderdale$1M
- Raul WeissMiami Beach$887K
- Naushad ShaikKissimmee$691K
- Parikshit SharmaWeston$462K
- Saumil OzaJacksonville$462K
- Brian BetenskySarasota$412K
- Antonio MorettaSarasota$312K
- Marcelo JimenezAtlantis$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.